Signify Health EBIT

The latest EBIT for SGFY is $95M as of December 2022. That compares with $34M in the prior-year period — up 177.3% year over year. That is below the Healthcare sector average of $110B. Investors often review this figure alongside Signify Health's historical trend and sector peers before judging valuation or financial health.

Over the past year, SGFY's EBIT moved from $34M to $95M — a 177.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Signify Health's operating scale or balance-sheet position.

Against Healthcare companies, SGFY currently prints $95M for EBIT, while the sector average sits near $110B. That is roughly 99.9% below the sector mean. Large gaps often invite a closer look at Signify Health's growth, margins, and balance sheet.

A EBIT figure of $95M for SGFY is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $110B. Explore the charts below for those layers of context.

After noting SGFY's EBIT ($95M), review year-over-year change from $34M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.